Symphony Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, today announced the appointment of Michael Messinger, CPA, to its Board of Directors (the "Board"). Mr. Messinger will also serve as the Chair of the Company's Audit Committee.

/PRNewswire/ -- Particles for Humanity, a life sciences company transforming early-stage technologies into products for people in low-resource settings, has...